ReviewJournal of oncology2022

Risk of Rash in PD-1 or PD-L1-Related Cancer Clinical Trials: A Systematic Review and Meta-Analysis.

Yuan Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.